News Releases

Clincierge® to Highlight Clinical Trial Recruitment and Retention-Boosting Services at World Orphan Drug Congress
-- Clincierge® CEO Scott Gray to Chair Day One of World Orphan Drug Congress --

PHILADELPHIA, April 19, 2016 /PRNewswire/ -- Clincierge® will showcase the company's unique hospitality-driven services that support clinical trial recruitment and patient retention at World Orphan Drug Congress U.S.A 2016, being held in Washington, DC from April 20 - 22. Additionally, Clincierge® Chief Executive Officer Scott Gray will chair the first day of the Main Conference, April 21.

Clincierge®/Gray Consulting International logo. (PRNewsFoto/Clincierge®/Gray Consulting..)

"Clinical trial sites for Orphan Drug studies are often widely dispersed, making multi-national trials and the necessity of patient travel a significant challenge for sponsors and CROs that can lead to slow recruitment and frequent patient drop-outs," says Scott Gray, chief executive officer of Clincierge®. "By providing patients with high-touch personalized support, regular one-on-one communication, upfront payments/rapid reimbursement, and expert logistical assistance for travel and accommodations, our services have had a dramatically positive effect on recruitment and retention for these complex trials."

Clincierge® will exhibit and be available for discussion at Booth #31 at the World Orphan Drug Congress.

About Clincierge®

Clincierge® reduces barriers to clinical trial participation, enhancing enrollment and reducing drop-outs. We help put patient needs first, providing personalized support, travel and accommodation logistics, and directly paying trial-related costs outside of reimbursable incidental expenses. Live assistance in the patient's own language helps answer study-related questions or concerns. We readily address special needs and complex trial designs, building custom solutions to specific study-related problems. We operate worldwide in 30 countries and 23 languages, adding service areas and capabilities as needed. Our goal: to reduce clinical testing time and cost, thus helping get new treatments to market as swiftly as possible. For more information on our company and services, please visit our website at http://www.clincierge.com.

Contact:

Scott A. Gray, CEO
Clincierge®, a division of Gray Consulting International
office: +1-215-413-7880

Logo - http://photos.prnewswire.com/prnh/20150723/240654LOGO

 

SOURCE Clincierge